MiguelDRegueiroMD

Gastroenterology • Cleveland, OH

Professor and Chief, Digestive Disease Institute, Cleveland Clinic

Join to view full profile

Dr. Regueiro is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Regueiro's full profile

Already have an account?

Office
9500 Euclid Avenue
A2
Cleveland, OH 44195

Summary

Gastroenterologist specializing in IBD patient-centered care.

Education & Training

Beth Israel Deaconess Medical CenterFellowship, Gastroenterology, 1994 - 1997
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1992 - 1994
Drexel University College of MedicineClass of 1992

Certifications & Licensure

OH State Medical License 1998 - 2026
PA State Medical License 1997 - 2024
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Fellow (AGAF) American Gastroenterological Association, 2007
Fellow (FACG) American College of Gastroenterology

Clinical Trials

Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis Start of enrollment: 2012 Feb 01
Completed
Phase 2
Evaluating a Shared Decision Making Program for Crohn's Disease Start of enrollment: 2014 Mar 01
Completed
Not Applicable
Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease Start of enrollment: 2013 Jul 01
Completed
Phase 4

Publications & Presentations

PubMed

Histologic Activity From Neoterminal Ileal Biopsies in Patients With Crohn's Disease in Endoscopic Remission is Associated With Postoperative Recurrence.
Ravi S Shah, Jessica H Hu, Salam Bachour, Abel Joseph, Hareem Syed
The American Journal of Gastroenterology. 2024-12-01
Psychometric evaluation of the Functional Assessment of chronic illness therapy-fatigue (FACIT-Fatigue) in adults with moderately to severely active Crohn's disease.
Miguel Regueiro, Sylvia Su, Aisha Vadhariya, Xian Zhou, Frederick Durand
Quality of Life Research. 2024-11-13
Biologics and Oral Small Molecules Are Not Associated With Increased Major Adverse Cardiovascular Events or Venous Thromboembolism in Inflammatory Bowel Disease.
Thabet Qapaja, Mohammed Abu-Rumaileh, Khaled Alsabbagh Alchirazi, Ahmad Gharaibeh, Ahmad Naser
Inflammatory Bowel Diseases. 2024-11-13

Journal Articles

A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD)
David A Schwartz, Mahrukh Riaz, Raymond K Cross, Seema A Patil, Sandra M Quezada, Barathi Sivasailam, Sara N Horst, Miguel Regueiro, Leyla Ghazi, Nature
A Practical Guide to the Safety and Monitoring of New IBD Therapies
Miguel Regueiro, MD, Inflammatory Bowel Diseases
Correction: ACG Clinical Guideline: Management of Crohn’s Disease in Adults
Gary R Lichtenstein, Bruce E Sands, Miguel D Regueiro, Kim L Isaacs, Nature

Lectures

Crohn’s Disease Complicated by an Intraabdominal Abscess – What First? Poke, Prod, or Cut?
AGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/8/2018

Authored Content

Reflecting on a Successful Virtual AIBD 2020 ConferenceDecember 2020

Press Mentions

New AGA Living Guideline Expands Recommended Drugs for Moderate to Severe UCNovember 26th, 2024
RSV Vaccination Lowers Risk for IBD Patients over 60, Study FindsOctober 29th, 2024
Miguel Regueiro, MD, on the Safety of JAK Inhibitors in IBDOctober 28th, 2024
Join now to see all

Professional Memberships